Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genmab
Pharma
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Five months after the FDA rejected Regeneron’s bid for approval of odronextamab, the European Union has signed off on the treatment.
Kevin Dunleavy
Aug 26, 2024 10:35am
Genmab shuffles C-Suite as portfolio grows
Aug 19, 2024 10:08am
AbbVie's Epkinly follows Roche's Lunsumio into FL
Jun 27, 2024 10:21am
Genmab to expand in New Jersey in bid to boost Epkinly rollout
Mar 28, 2024 4:29pm
Arbitrator sides with J&J, upholding Darzalex ruling vs. Genmab
Jan 23, 2024 10:23am
ESMO: Seagen, Genmab's Tivdak excel in cervical cancer study
Oct 22, 2023 10:30am
